Armstrong, K., Weber, B., FitzGerald, G., Hershey, J. C., Pauly, M. V., Lemaire, J., Subramanian, K. and Asch, D. A. (2003), ‘Life insurance and breast cancer risk assessment: adverse selection, genetic testing decisions, and discrimination’, American Journal of Medical Genetics Part A, 120A(3): 359–364.
Barigozzi, G. and Henriet, D. (2011), ‘Genetic information: comparing alternative regulatory approaches when prevention matters’, Journal of Public Economic Theory, 13(1): 23–46.
Godard, N., Raeburn, S., Pembrey, M., Bobrow, M., Farndon, P. and Ayme, S. (2003), ‘Genetic information and testing in insurance and employment: technical, social and ethical issues’, European Journal of Human Genetics, 11(Supplement 2): S123–S142.
Hoel, M., Iversen, T., Nilssen, T. and Vislie, J. (2006), ‘Genetic testing in competitive insurance markets with repulsion from chance: a welfarist analysis’, Journal of Health Economics, 25: 847–860.
Hudson, K. (2011), ‘Genomics, health care, and society’, The New England of Journal, 365(11): 1033–1041.
Joly, Y., Feze, I. N. and Simard, J. (2013), ‘Genetic discrimination and life insurance: a systematic review of the evidence’, BMC Medicine, 11: 25.
Oster, E., Shoulson, I., Quaid, K. and Dorsey, E. R. (2010), ‘Genetic adverse selection: evidence from long-term care insurance and Huntington disease’, Journal of Public Economics, 94(11–12): 1041–1050.
Polborn, M. K., Hoy, M. and Sadanand, A. (2006), ‘Advantageous effects of regulatory adverse selection in the life insurance market’, The Economic Journal, 116: 327–354.
Wilson, D. (2006), ‘Acquisition and disclosure of genetic information under alternative policy regimes: an economic analysis’, Health Economics, Policy and Law, 1(Pt 3): 263–276.